HSBC Holdings
RVMD icon

HSBC Holdings’s Revolution Medicines RVMD Stock Holding History

HSBC Holdings’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.5M Buy
71,816
+39,025
+119% +$5.7M 0.01% 886
2026
Q1 		$3.19M Buy
32,791
+29,953
+1,055% +$3.02M ﹤0.01% 1331
2025
Q4 		$227K Sell
2,838
-185,359
-98% -$12.2M ﹤0.01% 2646
2025
Q3 		$8.78M Sell
188,197
-43,688
-19% -$1.71M ﹤0.01% 975
2025
Q2 		$8.53M Buy
231,885
+11,697
+5% +$449K 0.01% 952
2025
Q1 		$7.78M Sell
220,188
-49,106
-18% -$1.99M ﹤0.01% 970
2024
Q4 		$11.8M Sell
269,294
-11,328
-4% -$572K 0.01% 887
2024
Q3 		$12.7M Buy
280,622
+265,709
+1,782% +$11.6M 0.01% 849
2024
Q2 		$567K Sell
14,913
-152,236
-91% -$5.69M ﹤0.01% 1914
2024
Q1 		$5.38M Buy
+167,149
New +$4.95M ﹤0.01% 1081
2022
Q4 		– Sell
-10,134
Closed -$204K – 3178
2022
Q3 		$204K Buy
+10,134
New +$223K ﹤0.01% 2624
2020
Q2 		– Sell
-10,655
Closed -$229K – 2831
2020
Q1 		$229K Buy
+10,655
New +$295K ﹤0.01% 2212

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

HSBC Holdings's RVMD Position: Q2 2026 in Review

HSBC Holdings increased its Revolution Medicines (RVMD) stake by 119% in Q2 2026, buying an estimated $5.7M and bringing the position to 71,816 shares worth $13.5M. The position accounts for 0.01% of the portfolio, ranked #886.

HSBC Holdings first reported a position in RVMD in Q1 2020 and has held it in 12 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • HSBC Holdings held 71,816 shares of Revolution Medicines worth $13.5M as of Q2 2026.
  • HSBC Holdings bought 39,025 Revolution Medicines shares in Q2 2026, an estimated $5.7M.
  • Revolution Medicines made up 0.01% of HSBC Holdings's portfolio in Q2 2026, its #886 holding.
  • HSBC Holdings first reported a position in Revolution Medicines in Q1 2020 and has held it in 12 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.